Andreas Pangerl
AbbVie
9 Papers
33 Citations
Andreas Pangerl is an academic researcher from AbbVie. The author has contributed to research in topics: Hepatitis C & Hepatitis C virus. The author has an hindex of 6, co-authored 9 publications.
Chat about Author
Papers
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis
Pietro Lampertico,José A. Carrión,Michael P. Curry,Juan Turnes,Markus Cornberg,Francesco Negro,Ashley Brown,Marcello Persico,Nicole Wick,Ariel Porcalla,Andreas Pangerl,Eric Crown,Lois Larsen,Yao Yu,Heiner Wedemeyer +14 more
TL;DR: Real-world evidence indicates that glecaprevir/pibrentasvir is a well-tolerated and highly effective pangenotypic treatment for a broad range of HCV-infected patients.
98
Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry
Thomas Berg,U Naumann,Albrecht Stoehr,Christoph Sick,Christine John,Gerlinde Teuber,W Schiffelholz,Stefan Mauss,Kristina Lohmann,Bettina König,Andreas Pangerl,Claus Niederau +11 more
TL;DR: Glecaprevir/pibrentasvir is a pangenotypic direct‐acting antiviral regimen approved for treating adults chronically infected with hepatitis C virus (HCV).
71
Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta-analysis.
Heiner Wedemeyer,Antonio Craxì,Eli Zuckerman,Douglas T. Dieterich,Robert Flisiak,Stuart K. Roberts,Andreas Pangerl,Zhenzhen Zhang,Marisol Martinez,Yanjun Bao,J.L. Calleja +10 more
TL;DR: Real‐world SVR12 rates for OBV/PTV/r±DSV±RBV were consistently high across HCV GT1 and four irrespective of cirrhosis status or prior HCV treatment experience, confirming effectiveness within a diverse patient population across multiple cohorts and countries.
First real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: Data from the German Hepatitis C-Registry
Thomas Berg,Uta Naumann,Albrecht Stoehr,C. Sick,Gerlinde Teuber,W Schiffelholz,Stefan Mauss,J Hettinger,H. Kleine,Andreas Pangerl,Claus Niederau +10 more
10